Nexpoint Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Nexpoint Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-35,000	Closed	-$2.17M	–	168
2020 Q4	$2.17M	Buy	+35,000	New	+$2.15M	0.71%	32
2020 Q2	–	Sell	-12,000	Closed	-$669K	–	197
2020 Q1	$669K	Buy	+12,000	New	+$733K	0.13%	105
2019 Q4	–	Sell	-388,200	Closed	-$19.7M	–	286
2019 Q3	$19.7M	Buy	+388,200	New	+$18.2M	1.23%	14

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nexpoint Asset Management's BMY Position: Q1 2021 in Review

Nexpoint Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 35,000 shares — an estimated $2.17M sold.

Nexpoint Asset Management first reported a position in BMY in Q3 2019 and held it in 3 quarters. The position peaked at $19.7M in Q3 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Nexpoint Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Nexpoint Asset Management sold 35,000 Bristol-Myers Squibb shares in Q1 2021, an estimated $2.17M.
Nexpoint Asset Management first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 3 quarters.
Nexpoint Asset Management's Bristol-Myers Squibb position peaked at $19.7M in Q3 2019.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Nexpoint Asset Management's 13F filing for Q1 2021, filed 17 May 2021.